Bulut, T. Et Al. 2016. Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma. Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology , (Vienna, Austria), 257.

Bulut, T., Yalcin, A. D., Celik, B., Genc, G. E., Kose, S., Gocmen, A. Y., ... Kiraz, K.(2016). Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma . Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology (pp.257). Vienna, Austria

Bulut, T. Et Al. "Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma," Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology, Vienna, Austria, 2016

Bulut, T. Et Al. "Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma." Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology , Vienna, Austria, pp.257, 2016

Bulut, T. Et Al. (2016) . "Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma." Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology , Vienna, Austria, p.257.

@conferencepaper{conferencepaper, author={T. Bulut Et Al. }, title={Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma}, congress name={Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology}, city={Vienna}, country={Austria}, year={2016}, pages={257} }